Ireland

Ipsen: A Track Record of Excellence in Ireland

These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with increasing global demand for its products. “Sales from [Somatuline® (lanreotide) and Decapeptyl® (triptorelin)] amounted to over EUR 700…

Ipsen: A Track Record of Excellence in Ireland

In Conversation

Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market, and more broadly in Ireland, during her extensive career at PwC. She also expands on the exciting opportunities that exist in the country to leverage the pharma and tech markets to help drive medical tech innovations in the future. She sheds…

The Pharma Legal Handbook: Ireland

Join industry executives in staying informed on pharma regulations in Ireland. Regulation, Pricing, Clinical Trials, Marketing, Manufacturing, Trademarks, Patents, and more! Get your pharmaceutical legal and regulatory questions answered in The…

Ireland

Ipsen: A Track Record of Excellence in Ireland

Ipsen: A Track Record of Excellence in Ireland

Ipsen: A Track Record of Excellence in Ireland

Ipsen: A Track Record of Excellence in Ireland

In Conversation

Interview: Jean Delaney – Pharma Leader, Partner, PwC Ireland

Interview: Eoin Vaughan – CEO; Dermot Gildea –…

Interview: David Adlam – Regional Manager, Ireland and…

The Pharma Legal Handbook: Ireland

The Pharma Legal Handbook: Ireland

The Pharma Legal Handbook: Ireland